Effects of Multi-glycosides of Tripterygium Wilfordiion in the Treatment of Sjögren's Syndrome in the Non-obese Diabetic Mouse Model.

Chun Lei Li,Jing He,Zhan Guo Li,Li Wu Zheng,Hong Hua
DOI: https://doi.org/10.3290/j.cjdr.a34433
2015-01-01
Abstract:Objective: To investigate the effects of the multi-glycosides of Tripterygium wilfordii (GTW) on Sjgren's syndrome (SS) in the non-obese diabetic (NOD) mouse model.Methods: Twenty-seven 8-week-old, female NOD mice were divided into the GTW group, the hydroxychloroquine (HCQ) group, and control (normal saline) group, and received corresponding treatment for 16 weeks. The treatment-induced changes in stimulated total saliva flow rate (STFR), level of serum anti-SSA/SSB, ratio of regulatory T (Treg) cells, histology of the submandibular gland (SMG) and the gene expression profile that is related to inflammation and autoimmunization were evaluated.Results: Compared to the untreated (control) mice, STRF, SMG index and Treg/CD4+ cell ratio were significantly higher, whereas anti-SSA, anti-SSB and lymphoid foci were remarkably lower in GTW-treated mice. HCQ-treated mice showed similar results except SMG index was not different from the untreated mice. NOD mice showed 19.03% altered gene expression with maturation from the age of 8 weeks to 24 weeks. Treatment with HCQ and GTW reduced the change in gene expression to 13.09% and 7.14%, respectively.Conclusion: GTW is as effective as HCQ in the treatment of Sjgren's syndrome in the NOD mouse model.
What problem does this paper attempt to address?